首页> 美国卫生研究院文献>other >Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a Wisconsin Oncology Network Study

【2h】

Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a Wisconsin Oncology Network Study

机译：长春瑞滨和exisulind的I / II期研究（至少70岁的晚期非小细胞肺癌患者的一线治疗）：威斯康星州肿瘤学网络研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

INTRODUCTIONExisulind is an apoptotic agent with preclinical activity in non-small cell lung cancer (NSCLC). Vinorelbine is safe and effective in older patients with advanced NSCLC. We assessed these agents together as palliative treatment for older patients with advanced NSCLC.

机译：引言Exisulind是一种在非小细胞肺癌（NSCLC）中具有临床前活性的凋亡因子。长春瑞滨对晚期NSCLC老年患者安全有效。我们将这些药物评估为晚期NSCLC老年患者的姑息治疗。

著录项

期刊名称 other
作者
Steven Attia; Anne M. Traynor; KyungMann Kim; Joseph J. Merchant; Tien Hoang; Harish G. Ahuja; Peter A. Beatty; Richard M. Hansen; Gregory A. Masters; Kurt R. Oettel; Gary R. Shapiro; Martha M. Larson; Marilyn L. Larson; Joan H. Schiller;
展开▼
作者单位

展开▼
年(卷),期 -1(3),9
年度 -1
页码 1018–1025
总页数 15
原文格式 PDF
正文语种
中图分类
关键词
Elderly exisulind sulindac sulfone non-small cell lung cancer vinorelbine phase I phase II;

机译：老年人;exisulind;舒林酸砜;非小细胞肺癌;长春瑞滨;I期;II期;

相似文献

外文文献
中文文献
专利

1. Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study. [J] . Attia S, Traynor AM, Kim K, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2008,第9期

机译：长春瑞滨和exisulind作为一线治疗至少70岁的晚期非小细胞肺癌的I / II期研究：威斯康星州肿瘤学网络研究。
2. The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study. [J] . Gridelli C The oncologist . 2001,第Suppla1期

机译：ELVIS试验：长春瑞滨单药单药治疗老年晚期非小细胞肺癌的一线治疗。老年肺癌Vinorelbine意大利研究。
3. 6501 ORAL Global Lung Oncology Branch trial 3 (GLOB 3): Quality of Life (QoL) results of a randomised multinational Phase III trial of oral and i.v. vinorelbine (NVB) plus cisplatin (CDDP) versus docetaxel (DTX) plus CDDP as first-line treatment for advanced non-small cell lung cancer (NSCLC) [J] . J.Rolski, T.Grodzki, C.P.Schneider, European Journal of Cancer Supplements . 2007,第4期

机译：6501 ORAL全球肺肿瘤科试验3（GLOB 3）：一项针对口服和静脉注射的跨国多国III期随机试验的生活质量（QoL）结果。长春瑞滨（NVB）加顺铂（CDDP）与多西他赛（DTX）加CDDP作为晚期非小细胞肺癌（NSCLC）的一线治疗
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
6. Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study [O] . Tien Hoang, Toby C. Campbell, Chong Zhang, -1

机译：伏立诺他和硼替佐米作为晚期非小细胞肺癌患者的三线治疗药物：威斯康星州肿瘤网络II期研究
7. Phase I/II Study of Vinorelbine and Exisulind as First-Line Treatment of Advanced Non-small Cell Lung Cancer in Patients at Least 70 Years Old: A Wisconsin Oncology Network Study [O] . Steven Attia, Anne M. Traynor, KyungMann Kim, 2008

机译：Vinorelbine的I / II类研究和exisulind作为至少70岁的患者晚期非小细胞肺癌的一线治疗：威斯康辛肿瘤学网络研究

Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a Wisconsin Oncology Network Study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅